A Study of the Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema

PHASE3CompletedINTERVENTIONAL
Enrollment

360

Participants

Timeline

Start Date

July 27, 2018

Primary Completion Date

June 29, 2020

Study Completion Date

June 8, 2021

Conditions
Diabetic Macular Edema
Interventions
DRUG

Brolucizumab

Intravitreal injection

DRUG

Aflibercept

Intravitreal injection

Trial Locations (78)

1606

Novartis Investigative Site, Sofia

1784

Novartis Investigative Site, Sofia

3007

Novartis Investigative Site, Bern

3570

Novartis Investigative Site, Alken

4000

Novartis Investigative Site, Roskilde

4032

Novartis Investigative Site, Debrecen

4400

Novartis Investigative Site, Nyíregyháza

8063

Novartis Investigative Site, Zurich

9000

Novartis Investigative Site, Varna

Novartis Investigative Site, Aalborg

10713

Novartis Investigative Site, Berlin

11412

Novartis Investigative Site, Tallinn

12808

Novartis Investigative Site, Prague

13620

Novartis Investigative Site, Bundang Gu

21034

Novartis Investigative Site, Dijon

27310

Novartis Investigative Site, Gaziantep

33000

Novartis Investigative Site, Bordeaux

33305

Novartis Investigative Site, Taoyuan District

35340

Novartis Investigative Site, Izmir

37075

Novartis Investigative Site, Göttingen

40000

Novartis Investigative Site, Shah Alam

40212

Novartis Investigative Site, Düsseldorf

40447

Novartis Investigative Site, Taichung

41380

Novartis Investigative Site, Kocaeli

44093

Novartis Investigative Site, Nantes

46150

Novartis Investigative Site, Petaling Jaya

48145

Novartis Investigative Site, Münster

49241

Novartis Investigative Site, Busan

50006

Novartis Investigative Site, Changhua

51014

Novartis Investigative Site, Tartu

69275

Novartis Investigative Site, Lyon

69317

Novartis Investigative Site, Lyon

75010

Novartis Investigative Site, Paris

75015

Novartis Investigative Site, Paris

76100

Novartis Investigative Site, Rouen

79106

Novartis Investigative Site, Freiburg im Breisgau

82000

Novartis Investigative Site, Montauban

82606

Novartis Investigative Site, Bratislava

83301

Novartis Investigative Site, Bratislava

89075

Novartis Investigative Site, Ulm

91101

Novartis Investigative Site, Trenčín

93009

Novartis Investigative Site, Bobigny

94000

Novartis Investigative Site, Créteil

110029

Novartis Investigative Site, New Delhi

119021

Novartis Investigative Site, Moscow

127486

Novartis Investigative Site, Moscow

160012

Novartis Investigative Site, Chandigarh

166830

Novartis Investigative Site, El Achrafiyé

168751

Novartis Investigative Site, Singapore

420066

Novartis Investigative Site, Kazan'

428028

Novartis Investigative Site, Cheboksary

600006

Novartis Investigative Site, Chennai

620109

Novartis Investigative Site, Yekaterinburg

641014

Novartis Investigative Site, Coimbatore

500 05

Novartis Investigative Site, Hradec Králové

100 34

Novartis Investigative Site, Prague

F 13008

Novartis Investigative Site, Marseille

04103

Novartis Investigative Site, Leipzig

H-1083

Novartis Investigative Site, Budapest

H 6725

Novartis Investigative Site, Szeged

H-9700

Novartis Investigative Site, Szombathely

500 034

Novartis Investigative Site, Hyderabad

LV 1002

Novartis Investigative Site, Riga

116-5311

Novartis Investigative Site, Beirut

70-933

Novartis Investigative Site, Beirut

LT 50161

Novartis Investigative Site, Kaunas

LT-08661

Novartis Investigative Site, Vilnius

NO-0407

Novartis Investigative Site, Oslo

80 809

Novartis Investigative Site, Gdansk

S308433

Novartis Investigative Site, Singapore

975 17

Novartis Investigative Site, Banská Bystrica

05845

Novartis Investigative Site, Poprad

02841

Novartis Investigative Site, Seoul

05505

Novartis Investigative Site, Seoul

06351

Novartis Investigative Site, Seoul

07301

Novartis Investigative Site, Seoul

701 85

Novartis Investigative Site, Örebro

06230

Novartis Investigative Site, Ankara

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY